Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUbsetfusmca Regulatory News (UMC)

Share Price Information for Ubsetfusmca (UMC)

Share Price is delayed by 15 minutes
Get Live Data
697.20    -3.75 (-0.53%)
Bid:
696.70
Ask:
697.70
Spread: 1.00 (0.144%)
Market Cap: -
UMC Live PriceLast checked at - London Stock Exchange

Intraday Ubsetfusmca Share Chart

Interim Management Statement

17 Feb 2012 07:00

RNS Number : 5991X
UMECO PLC
17 February 2012
 

17 February 2012

 Umeco plc

 

Interim Management Statement

 

Trading in line with Board expectations

 

Umeco plc ('Umeco' or 'the Company'), the global provider of advanced composite materials, today publishes its Interim Management Statement for the period from 1 October 2011 to 16 February 2012, incorporating financial information relating to the Group's continuing operations for the period from 1 October 2011 to 31 January 2012.

 

Current Trading

 

Umeco has delivered a robust performance overall in the four months to 31 January 2012 with revenue from continuing operations 8.7 per cent higher year-on-year. The Company's successful development continues to be underpinned by demand for lighter weight, higher strength materials driven by structural factors that include environmental regulation, fuel costs and safety considerations. The Company remains on track to deliver a full year result in line with the Board's expectations.

 

Structural Materials grew revenues by 19.8 per cent, benefiting from the Foxhound vehicle (LPPV) contract and the expansion of our distribution business into Finland and France during the second half of last year. As expected, margins were higher than in the first half of the current financial year, despite the effects of dual running costs associated with the relocation of operations in California.

 

Process Materials' revenues reduced by 6.2 per cent. As anticipated, strong demand from the aerospace & defence sector was offset by continued weakness in the Chinese wind energy market, which performed strongly in the comparative period. Excluding sales to the wind energy market, Process Materials' revenue increased by 5.2 per cent. Margins were similar to the first half of the current financial year, reflecting a favourable sales mix and continuation of benefits from actions taken to improve pricing.

 

Market Review

 

Aerospace & defence revenues, which accounted for 37.6 per cent of Group revenue in the period, grew by 21.6 per cent. Both business streams saw increasing activity from the 787 programme and from development of the A350XWB. Structural Materials' defence revenues benefited from the supply of ballistic protection materials used on the Foxhound contract, with this contract accounting for 14.0 percentage points of the revenue growth. In addition to their original order for 200 Foxhound vehicles, the Ministry of Defence has now indicated it will place a follow-on order for a further 100 vehicles.

 

Revenues in the wind energy market accounted for 9.6 per cent of total revenue and were 29.2 per cent lower than the comparative period. This reflects the previously highlighted weakness in the Chinese wind energy market, partially offset by strong demand from customers in the Americas. We continue to expect the Chinese market will have begun its recovery by the end of our current financial year and remain confident about the long term prospects of this market.

 

Revenue in the automotive sector grew by 35.8 per cent and represented 8.3 per cent of total revenue, reflecting a number of projects with high end automotive manufacturers.

 

Revenues into the recreation market were 19.2 per cent of total revenue, and grew by 22.6 per cent. This reflects strong demand in each of the motorsport, marine and sporting goods segments.

 

The Other Industrial segment accounted for 25.3 per cent of total revenue, with revenues to our advanced composite markets growing by 13.7 per cent. However we experienced lower demand for our specialist films not directly related to composites applications, which are supplied into southern European markets. This led to a 1.6 per cent overall reduction in Other Industrial revenue.

 

Overall, our markets continue to evidence the structural growth drivers that are generating increasing demand for our advanced composite materials.

 

 

Andrew Moss, Chief Executive of Umeco, said:

 

"We are pleased to have delivered an overall trading performance in line with our expectations. We are focused on our strategy of investing in innovative technology and knowhow, expanding our footprint in emerging markets, and delivering superior levels of service, concentrating on high quality business segments in long term growth markets that command attractive margins.

 

While the Board is mindful of the current uncertain macroeconomic environment, we remain on track to deliver our expectations for the current financial year."

 

- Ends -

 

 

Notes:

 

There will be a conference call on 17 February 2012 at 8.00am UK time for analysts and investors, with replay access available until 23 February 2012. Details are as follows:

 

Conference call:

Date

Friday 17 February 2012

Time

8.00am UK time

Telephone number

0800 073 8917 (dialing from the UK)

+44 (0) 1452 551 089 (dialing from overseas)

Conference ID

48854359

Replay facility:

Telephone number

0800 953 1533 (dialing from the UK)

+44 (0) 1452 55 00 00 (dialing from overseas)

Replay access

48854359#

 

Umeco will be hosting a Capital Markets Event in London on 22 March 2012 at which the Company will set out its strategy for sustainable growth including market growth potential and Umeco's competitive positioning. For more information about this event, please contact Sarah Hughes at Hudson Sandler on +44 (0) 20 7796 4133 or email Umeco@hudsonsandler.com.

 

For further information please contact:

 

Umeco plc Tel: +44 (0) 1926 331 800

Andrew Moss, Chief Executive

Steve Bowers, Finance Director

www.umeco.com

 

Hudson Sandler Tel: +44 (0) 20 7796 4133

Andrew Hayes

Andrew Leach

 

Notes:

 

The next scheduled update on the Group's performance will be the announcement of preliminary results for the year to 31 March 2012. These are scheduled to be released on 19 June 2012. Information in this announcement is based on unaudited management accounts. Revenue values are for continuing operations, and exclude amounts relating to Umeco's Supply Chain business trading as Pattonair. Completion of the divestment of Pattonair occurred on 29 July 2011.

 

Certain statements made in this announcement are forward looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from any expected future events or results referred to in these forward looking statements. Unless otherwise required by applicable law, regulation or accounting standard, we do not undertake any obligation to update or revise any forward looking statements, whether as a result of new information, future developments or otherwise. Nothing in this announcement should be construed as a profit forecast or estimate.

 

Further information on Umeco plc

 

Umeco plc ('Umeco') is an international provider of advanced composite materials primarily to the aerospace & defence, wind energy, recreation and automotive industries. Revenue from continuing operations to 31 March 2011 was £207.4 million and these operations had 863 employees in manufacturing and distribution operations in the UK, Europe and the USA.

 

Umeco is managed through two continuing business streams:

 

Structural Materials - development, manufacture and supply of advanced composite materials; and

 

Process Materials - development, manufacture and supply of vacuum bagging materials.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGMZNVZGZZM
Date   Source Headline
2nd Jan 202610:49 amRNSNet Asset Value(s)
31st Dec 202510:33 amRNSNet Asset Value(s)
30th Dec 202511:20 amRNSNet Asset Value(s)
29th Dec 202510:28 amRNSNet Asset Value(s)
24th Dec 202510:14 amRNSNet Asset Value(s)
23rd Dec 202510:26 amRNSNet Asset Value(s)
22nd Dec 202510:29 amRNSNet Asset Value(s)
19th Dec 202510:38 amRNSNet Asset Value(s)
18th Dec 202510:18 amRNSNet Asset Value(s)
17th Dec 202511:01 amRNSNet Asset Value(s)
16th Dec 202510:17 amRNSNet Asset Value(s)
15th Dec 202510:36 amRNSNet Asset Value(s)
12th Dec 202510:54 amRNSNet Asset Value(s)
11th Dec 202510:37 amRNSNet Asset Value(s)
10th Dec 202510:29 amRNSNet Asset Value(s)
9th Dec 202510:36 amRNSNet Asset Value(s)
8th Dec 202510:51 amRNSNet Asset Value(s)
5th Dec 202510:25 amRNSNet Asset Value(s)
4th Dec 202510:28 amRNSNet Asset Value(s)
3rd Dec 202510:30 amRNSNet Asset Value(s)
2nd Dec 202510:28 amRNSNet Asset Value(s)
1st Dec 202511:15 amRNSNet Asset Value(s)
27th Nov 202510:39 amRNSNet Asset Value(s)
26th Nov 202510:16 amRNSNet Asset Value(s)
25th Nov 202510:19 amRNSNet Asset Value(s)
24th Nov 202510:26 amRNSNet Asset Value(s)
21st Nov 202510:20 amRNSNet Asset Value(s)
20th Nov 202510:32 amRNSNet Asset Value(s)
19th Nov 202510:36 amRNSNet Asset Value(s)
17th Nov 202510:19 amRNSNet Asset Value(s)
14th Nov 202510:48 amRNSNet Asset Value(s)
13th Nov 202510:39 amRNSNet Asset Value(s)
12th Nov 202510:34 amRNSNet Asset Value(s)
11th Nov 202510:18 amRNSNet Asset Value(s)
10th Nov 202510:44 amRNSNet Asset Value(s)
7th Nov 202510:17 amRNSNet Asset Value(s)
6th Nov 202510:27 amRNSNet Asset Value(s)
5th Nov 202512:52 pmRNSNet Asset Value(s)
4th Nov 202510:36 amRNSNet Asset Value(s)
3rd Nov 202510:38 amRNSNet Asset Value(s)
31st Oct 202510:20 amRNSNet Asset Value(s)
30th Oct 202510:08 amRNSNet Asset Value(s)
29th Oct 202510:17 amRNSNet Asset Value(s)
28th Oct 202510:22 amRNSNet Asset Value(s)
27th Oct 202511:49 amRNSNet Asset Value(s)
24th Oct 202510:25 amRNSNet Asset Value(s)
23rd Oct 202510:33 amRNSNet Asset Value(s)
22nd Oct 202510:29 amRNSNet Asset Value(s)
21st Oct 202510:25 amRNSNet Asset Value(s)
20th Oct 202510:22 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.